Design of salbutamol EOP tablets from pharmacokinetics parameters

Pharmaceutical Development and Technology

Volumn 8, Issue 2, 2003, Pages 135-142

  Sinchaipanid, Nuttanan ^a   Pongwai, Sansanee ^b   Limsuwan, Pichet ^c   Mitrevej, Ampol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b RANGSIT UNIVERSITY   (Thailand)

^c KING MONGKUT'S UNIVERSITY OF TECHNOLOGY THONBURI   (Thailand)

Author keywords

CO2 laser; Osmogent; Osmotic pump tablet; Salbutamol

Indexed keywords

ACETONE; AEROSIL; CELLULOSE ACETATE; SALBUTAMOL; SODIUM CHLORIDE; TALC;

ARTICLE; CARBON DIOXIDE LASER; CONTROLLED DRUG RELEASE; DRUG COATING; FILM; FORCE; OSMOTIC PRESSURE; OSMOTIC PUMP; POROSITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TABLET COMPRESSION; TABLET FORMULATION;

ALBUTEROL; ALGORITHMS; BIOLOGICAL AVAILABILITY; BRONCHODILATOR AGENTS; EXCIPIENTS; HARDNESS; LASERS; MICROSCOPY, ELECTRON, SCANNING; OSMOTIC PRESSURE; POROSITY; PRESSURE; SOLUBILITY; TABLETS;

EID: 0037654815     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-120018479     Document Type: Article

References (24)

1. Hui, H.W.; Robinson, J.R.; Lee, V.H.L. Design and fabrication of oral controlled release drug delivery systems. In Controlled Drug Delivery: Fundamentals and Applications, 2nd Ed.; Robinson, J.R., Lee, V.H.L., Eds.; Marcel Dekker, Inc.: New York, 1987; 373-374.
2. Washington, N.; Wilson, C.G. Physiological factors affecting drug delivery and availability. In Encyclopedia of Pharmaceutical Technology, 1st Ed.; Swarbrick, J., Boylan, J.C., Eds.; Marcel Dekker, Inc.: New York, 1995; Vol. 12, 137-169.
3. Li, V.H.K.; Robinson, J.R.; Lee, V.H.L. Influence of drug properties and routes of drug administration on the design of sustained and controlled release systems. In Controlled Drug Delivery: Fundamentals and Applications, 2nd Ed.; Robinson, J.R., Lee, V.H.L., Eds.; Marcel Dekker, Inc.: New York, 1987; 7.
4. Theeuwes, F. Elementary osmotic pump. J. Pharm. Sci. 1975, 64 (12), 1987-1991.
5. Theeuwes, F. Osmotic Dispensing Device for Releasing Beneficial Agent. US Patent 3,845,770, Dec 11, 1974, Alza Corporation.
6. Gibaldi, M. Prolonged-release medication. In Biopharmaceutics and Clinical Pharmacokinetics, 4th Ed.; Gibaldi, M., Ed.; Lea & Febiger: Philadelphia, 1991; 24-145.
7. Theeuwes, F. Oral dosage from design: status and goals of oral osmotic system technology. Pharm. Int. 1984, 5 (Dec), 293-296.
8. Theeuwes, F.; Ayer, A.D. Laminated Osmotic System for Dispensing Beneficial Agent. US Patent 4,014,334, Mar 29, 1977, Alza Corporation.
9. Swanson, D.; Edgren, D. Theophylline Therapy Utilizing Osmotic Delivery. US Patent 4,484,921, Nov 27, 1984, Alza Corporation.
10. Ayer, A.D. Osmotic Device with Self-Sealing Passageway. US Patent 4,627,971, Dec 9, 1986, Alza Corporation.
11. Wong, P.S.L.; Barclay, B.L.; Deters, J.C.; Theeuwes, F. Osmotic System Comprising Plurality of Members for Dispensing Drug. US Patent 4,783,337, Nov 8, 1988, Alza Corporation.
12. Place, V.A.; Wong, P.S.L.; Barclay, B.; Childers, J.D. Oral Osmotic Device for Delivering Nicotine. US Patent 5,417,654, Sep 15, 1992, Alza Corporation.
13. Ramadan, M.A.; Tawashi, R. The effect of hydrodynamic conditions and delivery orifice size on the rate of drug release from the elementary osmotic pump system (EOP). Drug Dev. Ind. Pharm. 1987, 13 (2), 235-248.
14. Wu, T.; Pan, W.; Chen, J.; Zhang, R. Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets. Drug Dev. Ind. Pharm. 2000, 26 (2), 211-215.
15. Liu, L.; Khang, G.; Rhee, J.M.; Lee, H.B. Monolithic osmotic tablet system for nifedipine delivery. J. Control. Release 2000, 67 (2-3), 309-322.
16. Herbig, S.M.; Cardinal, J.R.; Korsmeyer, R.W.; Smith, K.L. Asymmetric-membrane tablet coatings for osmotic drug delivery. J. Control. Release 1995, 35 (2-3), 127-136.
17. Ramberger, R.; Burger, A. On the application of the Heckel and Kawakita equations to powder compaction. Powder Technol. 1985, 43, 1-9.
18. Diem, K.; Lentner, C. Scientific Tables, 7th Ed.; Ciba-Geigy Limited: Basel, 1973; 143.
19. 2 agonists: terbutaline, albuterol, and fenoterol. In Handbook of Pharmaco-kinetic/Pharmacodynamic Correlation; Derendorf, H., Hochhaus, G., Eds.; CRC Press: Florida, 1995; 299-321.
20. Shargel, L.; Yu, A.B.C. Modified-release drug products. Applied Biopharmaceutics & Pharmacokinetics, 4th Ed.; Prentice-Hall International, Inc.: Maryland, 1999; 169-203.
21. Dollery, C. Therapeutic Drugs, 2nd Ed.; Churchill Livingstone: New York, 1999; A60.
22. Steendam, R.; Lerk, C.F. Poly (DL-lactic acid) as a direct compression excipient in controlled release tablets. Part I. Compaction behavior and release characteristics of poly (DL-lactic acid) matrix tablets. Int. J. Pharm. 1998, 175 (1), 33-46.
23. Velasco, M.V.; Ford, J.L.; Rowe, P.; Rajabi-Siahboomi, A.R. Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J. Control. Release 1999, 57 (1), 75-85.
24. Magruder, P.R.; Barclay, B.; Wong, P.S.L.; Theeuwees, F. Constant Release System with Pulsed Release. US Patent 4,777,049, Oct 11, 1988, Alza Corporation.